Atlas FDA

Medtronic Evolut FX+ Transcatheter Aortic Valve, Evolut FX Delivery Catheter System, Evolut FX Loading System

FDA premarket approval P130021/S161 · decided 2024-04-19

Approval details

PMA number
P130021
Supplement
S161
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Medtronic Evolut FX+ Transcatheter Aortic Valve, Evolut FX Delivery Catheter System, Evolut FX Loading System
Generic name
Aortic valve, prosthesis, percutaneously delivered
Applicant
Medtronic, Inc.
Date received
2024-04-10
Decision date
2024-04-19
Days to decision
9 days
Decision code
OK30
Product code
NPT
Advisory committee
Cardiovascular
Expedited review
No
Location
Miinneapolis, MN
Statement
various manufacturing changes to the Evolut FX system to align with the Evolut system

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
VitalFlow Set with Balance™ Biosurface (K261335)Medtronic, Inc.2026-07-31
Concerto Versa™ Detachable Coil (K261866)Medtronic, Inc.2026-06-24
Elongated One-Piece Arterial (EOPA) 3D™ Arterial Cannulae (K260195)Medtronic, Inc.2026-04-23
Retrograde Coronary Sinus Perfusion Cannulae (K253203)Medtronic, Inc.2026-02-19
Clearview Intracoronary Shunts (K253998)Medtronic, Inc.2026-01-20
Bio-Medicus Life Support Catheter and Introducer (K251831)Medtronic, Inc.2026-01-15
Concerto Versa™ Detachable Coil (K253511)Medtronic, Inc.2026-01-14
C320LBB Delivery System (C320LBBS45), C320LBB Delivery System (C320LBBS48), C320LBB Delivery System (C320LBBL45), C320LBB Delivery System (C320LBBL48) (K253409)Medtronic, Inc.2025-12-19